Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy
European Cardiology Review · 17.08.2026
DOI: 10.15420/ecr.2026.35 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Cardiology Review, online erschienen am 17.08.2026. Verfasst von Sudesh Prajapathi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, All India Institute of Medical Sciences Bhopal, Madhya Pradesh, India. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, All India Institute of Medical Sciences Bhopal, Madhya Pradesh, India.
- Department of Community Medicine, People's College of Medical Sciences and Research Centre, People's University Bhopal, India.
- Department of Cardiology, King George's Medical University Lucknow, Uttar Pradesh, India.
ORCID-Profile: Sudesh Prajapathi, Aditi Mohta, Bhushan Shah, Akshyaya Pradhan
Zitieren
APA
Prajapathi, S., Mohta, A., Shah, B., & Pradhan, A. (2026). Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy. European Cardiology Review. https://doi.org/10.15420/ecr.2026.35
Vancouver
Prajapathi S, Mohta A, Shah B, Pradhan A. Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy. European Cardiology Review. 2026. doi:10.15420/ecr.2026.35
BibTeX
@article{Prajapathi2026,
author = {Prajapathi, Sudesh and Mohta, Aditi and Shah, Bhushan and Pradhan, Akshyaya},
title = {Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy},
journal = {European Cardiology Review},
year = {2026},
doi = {10.15420/ecr.2026.35}
}
EUVIMED